This inventor holds 2 USPTO granted patents. Top assignee: Adamed Sp. Z O.o.. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Jolanta Jaśkowska: Innovator in CNS Treatment
Introduction
Jolanta Jaśkowska is an accomplished inventor based in Kraków, Poland. She has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of central nervous system (CNS) diseases. With two patents to her name, her work is paving the way for new therapeutic options.
Latest Patents
Among her latest patents are arylosulfonamides designed for the treatment of CNS diseases. These arylsulphonamide derivatives, classified under formula (I) and their pharmaceutically acceptable salts, showcase the potential for addressing various CNS disorders. The compounds aim to provide effective treatments and preventive measures, thereby enhancing the quality of life for individuals suffering from such ailments. Interestingly, both patents focus on the same innovative compounds, underscoring their importance within her research endeavors.
Career Highlights
Jolanta is currently associated with Adamed Sp. z o.o., a company recognized for its commitment to innovative healthcare solutions. Her work at Adamed showcases her dedication to advancing medical science and bringing new treatments to the market.
Collaborations
In her professional journey, Jolanta collaborates with esteemed colleagues such as Piotr Kowalski and Monika Marcinkowska. This teamwork not only enhances her research capabilities but also fosters a collaborative environment that inspires creativity and innovation.
Conclusion
Jolanta Jaśkowska is an example of how dedicated inventors can significantly impact the medical landscape. Through her patents and collaborations, she continues to contribute to the betterment of healthcare solutions for CNS diseases, proving that innovation and teamwork can lead to remarkable advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile